Form 4: Paulson Boosts Bausch Health Stake
Insider Transaction Report
John Paulson, a director and 10% owner of Bausch Health Companies Inc., significantly increased his indirect beneficial ownership of common stock through recent purchases.
Summary
- John Paulson, a director and 10% owner of Bausch Health Companies Inc. (BHC), reported multiple purchases of common stock.
- On August 11, 2025, 2,000,000 shares were acquired at $6.35 per share.
- On August 12, 2025, an additional 1,156,640 shares were acquired at $6.88 per share.
- On August 13, 2025, 86,409 shares were acquired at $7.06 per share.
- These transactions increased Paulson's total indirect beneficial ownership to 36,034,751 shares of Bausch Health common stock.
- The shares are indirectly owned by investment funds managed by Paulson Capital Inc., where John Paulson is the controlling person.
Sentiment
Score: 8
Explanation: The significant increase in indirect beneficial ownership by a director and 10% owner indicates strong insider confidence, which is generally viewed positively by the market.
Positives
- A significant increase in indirect beneficial ownership by a key insider (director and 10% owner) signals strong confidence in the company's future prospects.
- The substantial volume of shares acquired (over 3.2 million shares) indicates a material commitment from a major stakeholder.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders may view the significant insider buying as a positive signal, potentially increasing confidence in the company's stock.
Key Dates
| Date | Description |
|---|---|
| 08/11/2025 | Acquisition of 2,000,000 shares of Common Stock at $6.35 per share. |
| 08/12/2025 | Acquisition of 1,156,640 shares of Common Stock at $6.88 per share. |
| 08/13/2025 | Acquisition of 86,409 shares of Common Stock at $7.06 per share. |
Recommendation
buyThe substantial increase in shareholdings by a key insider, John Paulson, who serves as both a director and a 10% owner, signals strong conviction in Bausch Health's future. Such significant insider buying often precedes positive developments or reflects a belief that the stock is undervalued, making it a compelling 'buy' signal for investors.
Keywords
Bausch Health, BHC, John Paulson, Insider Trading, Stock Purchase, Form 4, Beneficial Ownership, Pharmaceutical, Healthcare
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.